Tekmira Pharma's (Nasdaq: TKMR) Stock Surges 20% as Its Ebola Drug Moves Closer to Use

Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) stock surged some 20% to $17.23 Friday after an update on its Ebola treatment.

The U.S....

Tekmira Pharma (Nasdaq: TKMR) Stock Falls in Race for Ebola Treatment Approval

Tekmira Pharmaceutical (Nasdaq: TKMR) is on a roller coaster ride as investors bet on its chances to be the first drug to successfully develop...

Pages 1 of 1